Housed in Montréal’s renowned Mila artificial intelligence (AI) research institute, AI startup Valence Discovery recently came out of stealth mode earlier this year and announced $10.9 million CAD ($8.5 million USD) in funding.
The startup partners with leading pharmaceutical and biotech companies, using AI and machine learning to support their drug discovery efforts.
Co-founder Daniel Cohen said Valence is using next-generation AI methods to “build the world’s most powerful chemistry engine,” and compares formulating new drugs to solving a complicated Rubik’s Cube.
